Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30430 | 0.83 | — | — | |
| Dimethyl Sulfoxide SCHEMBL20866176 | 0.80 | — | — | |
| Acrylic Acid SCHEMBL15547249 | 0.80 | — | — | |
| Acrylic Acid SCHEMBL30443234 | 0.72 | LMNA (0.67) | LMNAALOX15HSD17B10ALDH1A1TSHR | |
| Acrylic Acid SCHEMBL30785183 | 0.72 | LMNA (0.67) | LMNAALOX15HSD17B10ALDH1A1TSHR | |
| Acrylic Acid SCHEMBL18042439 | 0.72 | LMNA (0.67) | LMNAALOX15HSD17B10ALDH1A1TSHR | |
| Acrylic Acid SCHEMBL1899595 | 0.72 | — | — | |
| Acrylic Acid SCHEMBL3683487 | 0.69 | — | — | |
| Acrylic Acid SCHEMBL31396361 | 0.69 | LMNA (0.62) | LMNAALOX15HSD17B10ALDH1A1TSHR | |
| Acrylic Acid SCHEMBL15066216 | 0.69 | LMNA (0.62) | LMNAALOX15HSD17B10ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160199502-A1 | Graft Copolymer Polyelectrolyte Complexes for Drug Delivery | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2016-07-14 | — | — | US | disclosed |
| US-20130183379-A1 | GRAFT COPOLYMER POLYELECTROLYTE COMPLEXES FOR DRUG DELIVERY | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2013-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160199502-A1 | Graft Copolymer Polyelectrolyte Complexes for Drug Delivery | PHOSPHO1, CLTA, PLTP | LMNA 2035/4885ALOX15 2118/4885HSD17B10 3173/4885 |
| US-20130183379-A1 | GRAFT COPOLYMER POLYELECTROLYTE COMPLEXES FOR DRUG DELIVERY | PHOSPHO1, CLTA, PLTP | LMNA 2035/4885ALOX15 2118/4885HSD17B10 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.